{"id":692541,"date":"2022-10-05T16:13:00","date_gmt":"2022-10-05T20:13:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/"},"modified":"2022-10-05T16:13:00","modified_gmt":"2022-10-05T20:13:00","slug":"miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/","title":{"rendered":"Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa"},"content":{"rendered":"
\n

EDEN PRAIRIE, Minn., Oct. 05, 2022 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced that CEO Jeff Ross will present at the 2022 Cell & Gene Meeting on the Mesa. The three day event held this year on October 11-13 features in-person and pre-recorded virtual presentations by leading public and private companies highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and regenerative medicine.<\/p>\n

Mr. Ross will deliver his remarks at the 2022 Cell & Gene Meeting on the Mesa in the Oxford Biomedica Ballroom on October 12th<\/sup>, 2022 at 6:30 pm ET. Registration for the conference is available here<\/a>.<\/p>\n

\n About Miromatrix<\/strong>
\n
Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients’ lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company’s initial development focus is on human livers and kidneys. For more information, visit\u00a0miromatrix.com<\/a>.<\/p>\n

\n Investor Contact<\/strong>
\n
Greg Chodaczek
347-620-7010
ir@miromatrix.com<\/a><\/p>\n

\n Media Contact:<\/strong>
\n
\n press@miromatrix.com<\/a>\n <\/p>\n

\u00a0<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

EDEN PRAIRIE, Minn., Oct. 05, 2022 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced that CEO Jeff Ross will present at the 2022 Cell & Gene Meeting on the Mesa. The three day event held this year on October 11-13 features in-person and pre-recorded virtual presentations by leading public and private companies highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and regenerative medicine. Mr. Ross will deliver his remarks at the 2022 Cell & Gene Meeting on the Mesa in the Oxford Biomedica Ballroom … <\/p>\n

Continue reading “Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-692541","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nMiromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"EDEN PRAIRIE, Minn., Oct. 05, 2022 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced that CEO Jeff Ross will present at the 2022 Cell & Gene Meeting on the Mesa. The three day event held this year on October 11-13 features in-person and pre-recorded virtual presentations by leading public and private companies highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and regenerative medicine. Mr. Ross will deliver his remarks at the 2022 Cell & Gene Meeting on the Mesa in the Oxford Biomedica Ballroom … Continue reading "Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-05T20:13:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTY3NiM1MTg5NTQzIzIyMTA1MjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa\",\"datePublished\":\"2022-10-05T20:13:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\\\/\"},\"wordCount\":228,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1OTY3NiM1MTg5NTQzIzIyMTA1MjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\\\/\",\"name\":\"Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1OTY3NiM1MTg5NTQzIzIyMTA1MjA=\",\"datePublished\":\"2022-10-05T20:13:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1OTY3NiM1MTg5NTQzIzIyMTA1MjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1OTY3NiM1MTg5NTQzIzIyMTA1MjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/","og_locale":"en_US","og_type":"article","og_title":"Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa - Market Newsdesk","og_description":"EDEN PRAIRIE, Minn., Oct. 05, 2022 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced that CEO Jeff Ross will present at the 2022 Cell & Gene Meeting on the Mesa. The three day event held this year on October 11-13 features in-person and pre-recorded virtual presentations by leading public and private companies highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and regenerative medicine. Mr. Ross will deliver his remarks at the 2022 Cell & Gene Meeting on the Mesa in the Oxford Biomedica Ballroom … Continue reading \"Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/","og_site_name":"Market Newsdesk","article_published_time":"2022-10-05T20:13:00+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTY3NiM1MTg5NTQzIzIyMTA1MjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa","datePublished":"2022-10-05T20:13:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/"},"wordCount":228,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTY3NiM1MTg5NTQzIzIyMTA1MjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/","name":"Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTY3NiM1MTg5NTQzIzIyMTA1MjA=","datePublished":"2022-10-05T20:13:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTY3NiM1MTg5NTQzIzIyMTA1MjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1OTY3NiM1MTg5NTQzIzIyMTA1MjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miromatrix-ceo-jeff-ross-to-present-at-the-2022-cell-gene-meeting-on-the-mesa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/692541","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=692541"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/692541\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=692541"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=692541"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=692541"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}